Skip to main content

Table 3 Bicarbonate prescription, laboratory findings, and dialysis efficiency through time

From: Changing the paradigm of bicarbonate (HCO3) hemodialysis prescription in Portugal: a 24-month prospective study

 

HCO3 prescription (mmol/L)

Serum HCO3 (mmol/L)

Serum pH

Serum Ca2+ (mmol/L)

Serum P+ (mmol/L)

Serum iPTH (pg/mL)

Albumin (g/dL)

CRP (mg/dL)

Kt/V

(1) Baseline

32

25.92 ± 1.82

7.38 ± 0.06

8.65 ± 0.6

4.27 ± 1.22

228.2 (IQR 365.8)

3.34 ± 0.33

0.7 (IQR 1.8)

1.68 ± 0.35

(2) 3 months

30 (IQR 2)

24.99 ± 1.97

7.37 ± 0.07

8.75 ± 0.47

4.03 ± 1.15

277.3 (IQR 310.75)

3.3 (IQR 0.6)

0.9 (IQR 1.5)

1.61 ± 0.31

(3) 6 months

30 (IQR 2)

24.64 ± 2.21

7.38 ± 0.48

8.7 (IQR 0.6)

3.9 ± 1

339.15 ± 206.52

3.33 ± 0.37

0.35 (IQR 1.5)

1.67 ± 0.36

(4) 9 months

28 (IQR 2)

24.35 ± 1.64

7.315 (IQR 0.06)

8.8 (IQR 0.4)

3.75 ± 1.05

199.5 (IQR 244.7)

3.29 ± 0.46

0.4 (IQR 1.95)

1.61 ± 0.29

(5) 12 months

28 (IQR 2)

23.72 ± 2.21

7.37 ± 0.07

8.71 ± 0.52

3.71 ± 1.24

145.3 (IQR 165.9)

3.37 ± 0.36

0.5 (IQR 0.9)

1.34 ± 0.29

(6) 15 months

28 (IQR 0)

22.44 ± 1.79

7.36 ± 0.07

8.76 ± 0.44

3.91 ± 1.07

209.51 ± 133.235

3.32 ± 0.33

0.5 (IQR 1.15)

1.61 (IQR 0.69)

(7) 18 months

28 (IQR 0)

22.85 ± 1.89

7.38 ± 0.09

8.73 ± 0.21

3.85 ± 1.02

160.3 (IQR 180.6)

3.5 ± 0.31

0.4 (IQR 1.05)

1.73 ± 0.4

(8) 21 months

28 (IQR 0)

23.16 ± 1.4

7.36 ± 0.05

8.8 (IQR 0.4)

3.78 ± 1.22

153.5 (IQR 178.6)

3.45 (IQR 0.52)

0.7 (IQR 1.2)

1.74 ± 0.39

(9) 24 months

28 (IQR 0)

23.4 ± 1.98

7.37 ± 0.07

8.9 (IQR 0.5)

3.68 (IQR 0.9)

181.5 (IQR 243.2)

3.45 (IQR 0.52)

0.5 (IQR 0.7)

1.72 ± 0.37

  1. Note: Continuous variables were presented as mean and standard deviation, or median and interquartile range (IQR) for variables with skewed distributions
  2. CRP C-reactive protein, IQR interquartile range